Mednet Logo
HomeQuestion

How do you approach adjuvant chemotherapy in early stage ER+ breast cancer who developed pneumonitis on ddAC?

4 Answers
Mednet Member
Mednet Member
Medical Oncology · H Lee Moffitt Cancer Center, University of South Florida

Neulasta with ddAC can cause an interstitial pneumonia or reaction like pneumonitis. If she was node positive, younger and you think rechallenging her is reasonable (the pneumonitis was grade 1-2 and resolved quickly on steroids) then you could try to do the remaining AC q3wk without Neulasta to see...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Yale

Generally agree. Would consider re-challenge with AC without neulasta only if the pneumonitis was mild and resolved. If more moderate to severe, would move on to weekly paclitaxel.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Warren Alpert Medical School of Brown University

I would have to be convinced that the potential benefit of administering an anthracycline over alternatives like TC was large enough to justify the risk - such as triple negative with positive nodes or ER+/HER2- with at least 4 positive nodes. In that case, one option to consider would be sequential...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · St Mary Medical Center (Long Beach CA)

Agree with the team.

Considering the patient’s age and presence of high risk features, TC is an option as well as a 3 week cycle. CBC should be carefully monitored given the risks of febrile neutropenia.

Register or Sign In to see full answer